ES2064104T3 - Procedimiento de preparacion de composiciones farmaceuticas del tipo de liberacion prolongada destinadas a la administracion por via oral. - Google Patents

Procedimiento de preparacion de composiciones farmaceuticas del tipo de liberacion prolongada destinadas a la administracion por via oral.

Info

Publication number
ES2064104T3
ES2064104T3 ES91909171T ES91909171T ES2064104T3 ES 2064104 T3 ES2064104 T3 ES 2064104T3 ES 91909171 T ES91909171 T ES 91909171T ES 91909171 T ES91909171 T ES 91909171T ES 2064104 T3 ES2064104 T3 ES 2064104T3
Authority
ES
Spain
Prior art keywords
administration
procedure
preparation
type
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91909171T
Other languages
English (en)
Inventor
Jean Pol Remol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EUROPHARMACEUTICALS SA
Original Assignee
EUROPHARMACEUTICALS SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EUROPHARMACEUTICALS SA filed Critical EUROPHARMACEUTICALS SA
Application granted granted Critical
Publication of ES2064104T3 publication Critical patent/ES2064104T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSICION FARMACEUTICA A BASE DE GRANULADOS DEL TIPO DE LIBERACION PROLONGADA DESTINADA A LA ADMINISTRACION POR VIA ORAL QUE COMPRENDE UNA SUSTANCIA FARMACOLOGICAMENTE ACTIVA Y UN EXCIPIENTE FARMACOLOGICAMENTE ACEPTABLE QUE ASEGURA UNA LIBERACION LENTA, REGULAR Y ESTABLE DE LA SUSTANCIA FARMACOLOGICAMENTE ACTIVA TRAS SU ADMINISTRACION EL EXCIPIENTE QUE COMPRENDE AL MENOS UNA MEZCLA DE UNA ETILCELULOSA DE BAJA VISCOSIDAD Y DE UNA ETILCELULOSA DE VISCOSIDAD ELEVADA, ESTANDO LA SUSTANCIA ACTIVA GRANULADA CON UNA SOLUCION ALCOHOLICA DE LA ETICELULOSA DE BAJA VISCOSIDAD, SIENDO LA RELACION EN PESO DE LA ETILCELULOSA DE BAJA VISCOSIDAD CON LA ETILCELULOSA DE VISCOSIDAD ELEVADA DEL ORDEN DE 1/5 A 1/20.
ES91909171T 1990-05-17 1991-05-16 Procedimiento de preparacion de composiciones farmaceuticas del tipo de liberacion prolongada destinadas a la administracion por via oral. Expired - Lifetime ES2064104T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE9000524A BE1004243A3 (fr) 1990-05-17 1990-05-17 Compositions pharmaceutiques du type a liberation prolongee destinees a l'administration par voie orale et leur procede de preparation.

Publications (1)

Publication Number Publication Date
ES2064104T3 true ES2064104T3 (es) 1995-01-16

Family

ID=3884799

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91909171T Expired - Lifetime ES2064104T3 (es) 1990-05-17 1991-05-16 Procedimiento de preparacion de composiciones farmaceuticas del tipo de liberacion prolongada destinadas a la administracion por via oral.

Country Status (7)

Country Link
EP (1) EP0483320B1 (es)
AT (1) ATE110564T1 (es)
BE (1) BE1004243A3 (es)
DE (1) DE69103724T2 (es)
DK (1) DK0483320T3 (es)
ES (1) ES2064104T3 (es)
WO (1) WO1991017743A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4333190C2 (de) * 1993-09-29 1996-05-30 Korsatko Werner Univ Prof Dr E Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung
US5679125A (en) * 1994-07-07 1997-10-21 Nikon Corporation Method for producing silica glass for use with light in a vacuum ultraviolet wavelength range
SI9500173B (sl) * 1995-05-19 2002-02-28 Lek, Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
SE0200539D0 (sv) * 2002-02-25 2002-02-25 Metcon Medicin Ab Granulation process and starch granulate

Also Published As

Publication number Publication date
EP0483320A1 (fr) 1992-05-06
ATE110564T1 (de) 1994-09-15
BE1004243A3 (fr) 1992-10-20
DE69103724D1 (de) 1994-10-06
DK0483320T3 (da) 1995-01-30
EP0483320B1 (fr) 1994-08-31
DE69103724T2 (de) 1995-04-06
WO1991017743A1 (fr) 1991-11-28

Similar Documents

Publication Publication Date Title
PL318649A1 (en) Preparation to be administered by inhalation
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
DE3766343D1 (de) Ibuprofen und aluminiumhydroxid enthaltendes arzneimittel.
SE8406081L (sv) Sett och komposition for framstellning av farmaceutiska preparat for oral administrering och med kontrollerad langtidsverkan
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
HUT67661A (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
ZA899796B (en) Therapeutically active substituted benzimidazole and process for its preparation
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
IL92799A0 (en) Benzimidazole derivatives with gastric acid inhibition and process for its preparation
JPS5781409A (en) External plaster
DK0483320T3 (da) Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
DK0911038T3 (da) Vandfri sammensætning omfattende lactulose
ATE181828T1 (de) Oral anzuwendendes arzneimittel bestehend aus ibuprofen
SE8304818L (sv) Medicin med magsarslekande, spasmolytisk och lokalanesteserande verkan
MY102368A (en) Solid sustained-release composition
SE8303012D0 (sv) Farmaceutisk komposition
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it
NO964775L (no) Fast farmasöytisk adenosinholdig preparat
KR960007619A (ko) 신규 알긴산 유도체 및 그 제조방법
KR890002058A (ko) 간질 및 불안 상태의 예방 및 치료용 2,4,6-트리스-3-급-부틸아미노-1,-3,-5-트리아진

Legal Events

Date Code Title Description
FC2A Grant refused

Effective date: 19930504

FG2A Definitive protection

Ref document number: 483320

Country of ref document: ES